[
    [
        {
            "time": "2021-09-15",
            "original_text": "Pfizer Stock Sinks As Market Gains: What You Should Know",
            "features": {
                "keywords": [
                    "Pfizer",
                    "stock",
                    "sinks",
                    "market",
                    "gains"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Pfizer Stock Sinks As Market Gains: What You Should Know",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-09-15",
            "original_text": "Moderna asks FDA to evaluate COVID-19 vaccine booster candidate",
            "features": {
                "keywords": [
                    "Moderna",
                    "FDA",
                    "evaluate",
                    "COVID-19",
                    "vaccine",
                    "booster"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-09-15",
            "original_text": "AbbVie Stock: Why A New FDA Order Hit It Harder Than Rivals Pfizer, Lilly",
            "features": {
                "keywords": [
                    "AbbVie",
                    "stock",
                    "FDA",
                    "order",
                    "hit",
                    "Pfizer",
                    "Lilly"
                ],
                "sentiment_score": -0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 3,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-09-15",
            "original_text": "Why AbbVie Is Down More Than 7% Today",
            "features": {
                "keywords": [
                    "AbbVie",
                    "down",
                    "7%",
                    "today"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 6,
                "Impact": 7,
                "Duration": 2,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-09-15",
            "original_text": "UPDATE 1-U.S. administers third dose of COVID-19 vaccine to over 1 million people - CDC",
            "features": {
                "keywords": [
                    "U.S.",
                    "administers",
                    "third",
                    "dose",
                    "COVID-19",
                    "vaccine",
                    "CDC"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-09-15",
            "original_text": "Column: Following FDA approval of Pfizer's shot, the anti-vaccine movement cooks up new conspiracy theory",
            "features": {
                "keywords": [
                    "FDA",
                    "approval",
                    "Pfizer",
                    "shot",
                    "anti-vaccine",
                    "movement",
                    "conspiracy"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-09-15",
            "original_text": "COVID SCIENCE-Antibody levels higher after Moderna shot; Lilly arthritis drug used with steroid cuts death risk",
            "features": {
                "keywords": [
                    "COVID",
                    "science",
                    "antibody",
                    "levels",
                    "Moderna",
                    "shot",
                    "Lilly",
                    "arthritis",
                    "drug",
                    "death",
                    "risk"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "biotechnology",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-09-15",
            "original_text": "UPDATE 1-Pfizer, Merck launch new trials of oral COVID-19 drugs",
            "features": {
                "keywords": [
                    "Pfizer",
                    "Merck",
                    "launch",
                    "trials",
                    "oral",
                    "COVID-19",
                    "drugs"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-09-15",
            "original_text": "Majority of U.S. companies may mandate COVID-19 vaccine in coming months - survey",
            "features": {
                "keywords": [
                    "U.S.",
                    "companies",
                    "mandate",
                    "COVID-19",
                    "vaccine",
                    "survey"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-09-15",
            "original_text": "The debate over COVID-19 booster shots picks up steam. Will they be limited to certain high-risk Americans?",
            "features": {
                "keywords": [
                    "debate",
                    "COVID-19",
                    "booster",
                    "shots",
                    "high-risk",
                    "Americans"
                ],
                "sentiment_score": 0.4,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "The debate over COVID-19 booster shots picks up steam. Will they be limited to certain high-risk Americans?",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]